Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043504 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qiulei Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Cysts, Fibrosis, Kidney Diseases, Cystic, Rho Guanine Nucleotide Exchange Factors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Natural Science Foundation, Beijing Bethune Public Welfare Foundation, President Foundation of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Nephronophthisis (NPHP) is the most prevalent monogenic disease leading to end-stage renal failure in childhood. RhoA activation is involved in NPHP pathogenesis. This study explored the role of the RhoA activator guanine nucleotide exchange factor (GEF)-H1 in NPHP pathogenesis. We analyzed the expression and distribution of GEF-H1 in NPHP1 knockout (NPHP1KO) mice using Western blotting and immunofluorescence, followed by GEF-H1 knockdown. Immunofluorescence and renal histology were used to examine the cysts, inflammation, and fibrosis. A RhoA GTPase activation assay and Western blotting were used to detect the expression of downstream GTP-RhoA and p-MLC2, respectively. In NPHP1 knockdown (NPHP1KD) human kidney proximal tubular cells (HK2 cells), we detected the expressions of E-cadherin and α-smooth muscle actin (α-SMA). In vivo, increased expression and redistribution of GEF-H1, and higher levels of GTP-RhoA and p-MLC2 in renal tissue of NPHP1KO mice were observed, together with renal cysts, fibrosis, and inflammation. These changes were alleviated by GEF-H1 knockdown. In vitro, the expression of GEF-H1 and activation of RhoA were also increased, with increased expression of α-SMA and decreased E-cadherin. GEF-H1 knockdown reversed these changes in NPHP1KD HK2 cells. Thus, the GEF-H1/RhoA/MLC2 axis is activated in NPHP1 defects and may play a pivotal role in NPHP pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
ORCID-Profile: Qiulei Hu, Jiayong Lai, Liangzhong Sun
Förderung
- Guangdong Natural Science Foundation
- Beijing Bethune Public Welfare Foundation
- President Foundation of Nanfang Hospital, Southern Medical University
Zitieren
APA
Hu, Q., Lai, J., Chen, H., Cai, Y., Yue, Z., Lin, H., & Sun, L. (2023). Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043504
Vancouver
Hu Q, Lai J, Chen H, Cai Y, Yue Z, Lin H, et al. Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043504
BibTeX
@article{Hu2023,
author = {Hu, Qiulei and Lai, Jiayong and Chen, Huamu and Cai, Yong and Yue, Zhihui and Lin, Hongrong and Sun, Liangzhong},
title = {Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043504}
}
EUVIMED